Kiran Mazumdar Shaw is the Chairman & Managing Director of Biocon Ltd, India's biggest biotechnology company.

In 2004, she became India's richest woman. Kiran Mazumdar Shaw was born on March 23, 1953 in Bangalore. Education: She had done her schooling at Bishop Cotton Girls School and Mount Carmel College at Bangalore. After doing completing her B.Sc. in Zoology from Bangalore University in 1973, she went to Ballarat University in Melbourne, Australia and qualified as a master brewer.

Career
Kiran Mazumdar Shaw begin with her professional career as the trainee in brewer in Carlton & United Beverages in 1974. In the year 1978, she joined as Trainee Manager with Biocon Biochemicals Limited in Ireland. In the same year, Kiran Mazumdar Shaw led the founded Biocon India in collaboration with Biocon Biochemicals Limited, with an initial capital of Rs.10, 000 Biocons initial operation was only to extract an enzyme from papaya. Under the guidance of Kiran Mazumdar Shaws stewardship Biocon transformed from an industrial enzymes company to an integrated biopharmaceutical company with strategic research initiatives. Awards These include ET Businesswoman of the Year, Best Woman Entrepreneur, Model Employer, Ernst & Youngs Entrepreneur of the Year Award for Life Sciences & Healthcare, Leading Exporter, Outstanding Citizen, Technology Pioneer, etc. Government of India also felicitated her with Padmashri (1989) and Padma Bhushan (2005). Kiran Mazumdar Shaw inspires her team with a shared vision of the future. Transformed them into, and efficient workforce, she dont necessarily lead from the front, as she loves t to delegate responsibility amongst their teams. While their enthusiasm is often infectious, they can need to be supported by people. In Biocon, both transactional and transformational leadership has been seen. The transactional leaders (or managers) ensure that routine work is done reliably, while the transformational leaders look after initiatives that add value. High regulating and low nurturing has seen as the key factor of her behavior, she always defines the role of the group members telling them what task to do and how and when and where to do them. She is the master of her field so she has developed her trade like that. She always initiates the problem solving and decision making are solely by her even the solution and decision are announced by her and its implementations are closely supervised by her. The above behavior keeps her under the authoritative and directive leadership trade. Kiran Mazumdar Shaw is known as her authority under her leadership Biocon has immerged as the most admired company in biotechnology for their research work and wealth creation. She is the great believer in herself and always led the research project under her umbrella.
Biocon wins Bio-Excellence Award for Outstanding Achievement in the Healthcare Sector at Bangalore Bio 2009

Biocon among Top 20 Indian companies in Forbes Best Under A Billion list. Biocon wins Bio-Excellence Award for Outstanding Achievement in the Healthcare Sector at Bangalore Bio Syngene wins Bio-Excellence Award for outstanding achievement in the Biotech Service Sector at Bangalore Bio Biocon bags IDMA "Best Patent of the year" award BIOMAb EGFR was voted Bio-Spectrum Asia-Pacific Product of the year, 2008 Biocon wins prestigious BioSingapore Asia Pacific Biotechnology Award for Best Listed Company 2008 Biocon is ranked among the top 20 global biotechnology companies (Source: Med Ad News, June 2008) Biocon is the 7th largest biotech employer in the world (Source: Med Ad News, June 2008) 2007 Syngene receives "BioServices Company of the Year", BioSpectrum Awards Biocon's BIOMAb EGFR wins "Product of the Year", BioSpectrum Awards 2006 Best IT User Award in the Pharmaceutical Sector, NASSCOM 2004 India's first and No. 1 biotech company with a global ranking of 16* (Source: Biospectrum July 2004) Biocon in India's top 5 Life Sciences companies (at close of trade as on July 30, 2004) Best Reinvention of HR Function Award, Indira Group, Mumbai Best Employer Of India Award, Hewitt 2003 Bio-Business Award for bio-entrepreneurship, Rabo India Express Pharma Pulse Award for excellence in the pharmaceutical industry 2001 Biotech Product, Process Development and Commercialisation Award, Department of Biotechnology, Ministry of Science and

Technology, Government of India 2000 Technology Pioneer Recognition, World Economic Forum 1985 Export Performance Award, Karnataka State Financial Corporation (KSFC) National Award for Best Small Industry, Government of India Kiran Mazumdar-Shaw: 2010 Featured on the Forbes list of The Worlds 100 Most Powerful Women. Featured on the Financial Times Top 50 Women in Business list. Named among TIME magazines 100 most influential people in the world. 2009 Honoured with 'Nikkei Asia Prize' for Regional Growth Honoured with 'Express Pharmaceutical Leadership Summit Award' for Dynamic Entrepreneur 2008 Honorary Degree of Doctor of Science from the Heriot-Watt University, Edinburgh Honorary Degree of Doctor of Science from the University of Glasgow 2007 Honoured with the, 'Veuve Clicquot Initiative For Economic Development For Asia' award Honorary Doctor of Technology, University of Abertay, Dundee ( UK ) 2005 Padmabhushan Award , one of India's highest civilian honours, from the President of India, Dr. APJ Abdul Kalam Honorary Degree of Doctor of Science (Honoris Causa) from Indian Institute of Technology, Roorkee The Indian Chamber of Commerce Lifetime Achievement Award Honorary Doctorate from Manipal Academy of Higher Education (MAHE), in recognition of outstanding achievements in

biotechnology and industrial enzymes Rotary Award for Corporate Citizenship Business Leader of the Year Award - Biotechnology, Chemtech-Pharma Bio Awards 2004 Honorary Doctorate of Science from Ballarat University, in recognition of pre-eminent contribution to the field of biotechnology Business Woman Of The Year Award, The Economic Times 2003 Alumni High Achiever Award, Australian Alumni Association 2002 Karnataka Rajyotsava Award for pioneering biotechnology in India, the Government of Karnataka Best Entrepreneur: Healthcare & Life Sciences Award, Ernst & Young Sir M. Visvesvaraya Memorial Award for contribution to biotechnology, Federation of Karnataka Chambers of Commerce & Industry (FKCCI) 1999 Woman of the Year Award, International Women's Association, Chennai 1998 Golden Jubilee Felicitation, Mount Carmel College, Bangalore 1989 Padmashri for pioneering biotechnology in India, Government of India 1987 Outstanding Young Person Award, Jaycees India 1983 Best Small Scale Industry in Karnataka Award, Rotary Club, Karnataka Best Model Employer Award, Rotary Club, Karnataka Outstanding Contribution Award, AWAKE 1982

Best Woman Entrepreneur Award, National Institute of Marketing Management, India

www.biocon.com/biocon_aboutus_awards.asp www.iloveindia.com/indian-heroes/kiran-mazumdar-shaw http://www.businessandeconomy.org/29122005/story http://news.oneindia.in/2009/05/11/kiranmazumdar-shaw-awarded-prestigious-nikkei-asia-prize http://www.innovationcouncil.gov.in/members/kiranmazumdarshaw.php http://www.wewit.in/content/kiran-mazumdar-shaw http://biospectrumindia.ciol.com/content/biospecial/104010801.asp http://www.adport.net/success-stories/kiranmazumdarstory.html http://www.business-standard.com/india/news/kiran-mazumdar-shaw-gets-veuve-clicquotaward/301408/ http://abhayjere.com/qbt.aspx
A woman dares where men fear to tread is perhaps the one best way one would define the life and struggles of Indias biotech pioneer and Biocon chairperson Kiran Mazumdar-Shaw, who is arguably the most influential woman entrepreneur in corporate India. As a woman who qualified as a Master Brewer from Ballarat University, Australia, in 1975, she has certainly made tremendous strides in a business that was, at that time, unknown to her and to the risk averse mind of the Indian entrepreneur. Even as we trudge judiciously into her office to meet her, we realise that the perception of biotech in India remains that of a high risk business reserved for people who can consistently pump in heavy capital over a long term basis; and that, to us, makes Kirans achievements all the more exemplary. Meeting Kiran Mazumdar-Shaw is quite an experience, especially after the Economist sub-titled her Indias Biotech Queen and Fortune placed her in the list of Worlds 50 Most Powerful Women. Well, our greetings are quite fitting, akin to royalty. The honours have unsurprisingly kept pouring in for her, the most important ones being the Padmashri (1989) & Padma Bhushan (2005). She is also the Chairperson and Mission Leader of CIIs National Task Force on Biotechnology. Apart from that, she is president of ABLE (Association of Biotechnology Led Entrepreneurs) and chairperson, Karnataka Vision Group on Biotechnology.

Bangalore, May 11 (ANI/Business Wire India): Kiran Mazumdar Shaw, Chairman and Managing Director, Biocon Limited has been honoured with the 'Nikkei Asia Prize' 2009 for Regional Growth. Japan's prestigious business daily Nihon Keizai Shimbun (Nikkei) awards Nikkei Asia Prizes annually to individuals or institutions from Asia Pacific region recognizing outstanding achievements that improve the quality of life in Asia.

"My vision is to grow into a global bio-therapeutics company with very innovative and proprietary products and technologies. Two years is a very short time to predict drug discovery but we hope to discover a few new drug molecules in three-four years through a new in-house initiative."

A successful technocrat of global standing, Ms. Shaw heads Indias leading Biopharmaceutical enterprise, Biocon. She is highly respected in the corporate world and has recently made it to the 2010 Times 100 list, as The Most Influential Person. She was also featured on the Forbes list of The Worlds 100 Most Powerful Women. Her pioneering efforts in biotechnology have drawn global recognition both for Indian industry and Biocon. She chairs Karnatakas Vision Group on Biotechnology and has also served on the Board of Science Foundation, Ireland. She presently serves on the Advisory Council of the Governments Department of Biotechnology where she has been instrumental in bringing government, industry and academia together. She is associated with the Indian Pharmacopoeia Commission, an autonomous body of the Government of India. She is also a founder member of the Society for the formation of Institute for Stem Cell Biology and Regenerative Medicine. She has recently been nominated as Member of the Board of Trade, Directorate General of Foreign Trade, Ministry of Commerce & Industry.

There are few people who can show the way among the multitudes, who are exceptional leaders. One such person is Kiran Muzumdar Shaw. Kiran is the Chairperson and Managing Director of Biocon Ltd, India's biggest biotechnology company and one of the 20 leading biotech companies in the world. Kiran never dreamt of becoming an entrepreneur. The cards were stacked against her: her father lost his savings in a bad investment, she had no background in biotech or entrepreneurship, and she had to overcome the stigma of being a female entrepreneur in the sciences. At the time of Biocon's founding, banks were unwilling to give loans for the unfamiliar field or biotechnology. With the help of fellow female biotech mentor and just Rs.10, 000, Kiran founded Biocon in 1978. The company began by developing a process to extract papain, an enzyme from payaya. The fermentation process subsequently led to the development of several other industrial enzymes. By the year 1990, Biocon became capable enough to kick-start an in-house research programme in solid substrate fermentation technology that permitted it to create enzymes from pilot to plant level. Later, she led the company to the realm of biopharmaceuticals fully integrated bio-pharmaceutical venture comprising a well-balanced business assortment of products and services with specific research on diabetes, oncology and auto-immune disease. In 2004, Biocon's unprecedented success made Kiran India's richest woman. Outside of business, Kiran is also a vocal spokesperson of the biotech industry. She is currently on the Advisory Council of the Governments Department of Biotechnology, where she has been instrumental in bringing together government, industry and academia in order to plan a lucid and progressive growth path for Biotechnology in India. Most recently, she has been invited to join the Prime Ministers Council on Trade & Industry in India and the US-India CEO Forum. She is in recipient of several prestigious awards, including: The Economic Times Business Woman of the Year Award in 2004, Lifetime Achievement Award from Indian Chamber of Commerce in 2005 and Wharton Infosys Business Transformation Award in 2006

BioSpectrums first ever Awards for the biotech industry were presented on 20 December 2003 in Bangalore. A report.

"Success is one percent inspiration and 99 percent perspiration." Success is also appreciationboth for measure of success and enabler for greater success. That was the philosophy behind BioSpectrum Awards. With this theme, the stage was set to felicitate the achievers of the biotech industry. Well-known biotechnology expert and Father of Indias Green Revolution, Prof. M S Swaminathan was conferred the magazines "Life Time Achievement" Award, while Ms Kiran Mazumdar-Shaw, Chairperson and Managing Director of the Rs 286-crore Biocon India, was honoured with the "BioSpectrum Person of the Year" Award.

BioSpectrum Awards
Life Time Achievement:
Prof. MS Swaminathan

Person of the Year:

Ms Kiran Mazumdar-Shaw

Entrepreneur of the Year:

Dr Krishna M Ella

State of the Year:

Andhra Pradesh

Product of the Year:

AVADIS

he Back Vision Beyond BIOCON aims at standing as one of the top ten corporate biotech conglomerates, worldwide. Kiran fervently hopes to see a BIOCON molecule in the world market in the next five years, placing India in the coveted league of rare and vibrant biotech forerunners. India is one of the biggest centers for biotechnology in the areas of health care and pharmaceuticals, she asserts. Her vision was ratified when the Karnataka government founded a biotechnology Vision group, with Kiran as its Chairman. Kiran advises the government on the policy initiatives that it should introduce in the field of

biotechnology. Kiran has also been selected as the honorary Consul of Ireland for pharma-biotech ventures between India and Ireland. The $350 billion pharmaceutical industry revolves around merely 400 drug targets, which are known to wreck human health. The functional genomics should explode the universe to an ambit of 10,000 targets or more. In short, trillions of dollars of business have been set to explode globally " a potential, which had Bill Gates (Microsoft) subscribing to it too". Kiran has identified such an opportunity and skillfully developed it to place India in the global map of biotechnology. A position as one of the top ten G-7 or G-10 countries in the world is what India should aim for, Kiran states with passion.

Kiran Mazumdar-Shaw gets Veuve Clicquot award

Annoucement / Mumbai October 16, 2007

Biocon has announced that Kiran Mazumdar-Shaw, Chairperson and Managing Director of the Company has been honoured with the 'Veuve Clicquot Initiative For Economic Development For Asia award. The award for Economic Development was introduced for the first time in 2007. There were three Economic Development awards that went to three women from Asia (India) Latin America (Bolivia) and Africa (Algeria). This is a special award that looks beyond business success to CSR and a combined effort to bring about economic change in developing economies. Ms. Kiran Mazumdar-Shaw has been nominated as the very first winner for Asia. Ms. Shaw was presented the award at Reims, one hour away from Paris over a unique two-day function.

One of the first steps Kiran took was to set up an office in a small garage and advertise for staff. To her chagrin, she found that instead of interviewing people, she was being interviewed by them! Few liked the idea of working for a woman, that too one who was so young (she was 25). Even more difficult was getting capital to begin the venture. Although there were government schemes for funding small scale industries, Kiran was time and again turned away from banks unwilling to give a loan to a woman with a risky venture in an unheard of field. She did eventually get a financial backer, but it took years before Kiran s skills and vision got the company to its peak. When it eventually did, Biocon stormed the world, having grown from a small company producing industrial enzymes to a mammoth biopharmaceutical company which ventured into innovative research programs. From a $250 start-up company to a $1 billion venture, Biocon Ltd. has made a huge impact on the lives of ordinary people. Under the mentorship of Kiran, the company focuses on insulin, antibodies and cancer vaccines with the aim to create drugs which are affordable especially to the poor of India. When TIME magazine named Kiran in its annual list of the 100 most influential people in the world, cyclist Lance Armstrong wrote Thank you, Dr. Shaw, for treating cancer like the global crisis it has become. Kiran is a true philanthropist, donating about $2 million towards health insurance coverage for villagers in India. She also provided $10 million as funds to set up the Mazumdar-Shaw Cancer Centre inBangalore; it will provide free treatment to poor patients. In fact, Kiran featured in Forbes magazine s list of Asia s top philanthropists.

http://www.hi5sms.in/kiran-mazumdar-richest-indian-lady-hi5sms-in.php